Mutations of genes encoding regulatory subunit of PIK3 have been reported in a tumorigenic thymic carcinoma cell line, using targeted exome sequencing, predicting the efficacy of PIK3 inhibitors [24]. The gene discussed is PIK3CG; the disease is thymic carcinoma.